Annie Moisan

Annie Moisan is a seasoned translational science leader with a focus on metabolic and immune diseases. They served as a Postdoctoral Research Fellow at Harvard Medical School, generating genetically engineered models to understand kidney development. At Roche, they held various leadership roles, driving discovery strategies in nephrology and advancing safety paradigms through bioengineered human models. Most recently, as Program Director at Wellcome Leap, they led multi-disciplinary teams to innovate in bioengineering functional organ units for transplantation and immune therapy. Annie is dedicated to bridging the gap between preclinical and clinical research, fostering collaboration to enhance therapeutic translation.